Two Sigma Investments
INMB icon

Two Sigma Investments’s INmune Bio INMB Stock Holding History

Two Sigma Investments’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-35,591
Closed -$82.2K – 3784
2025
Q2 		$82.2K Buy
35,591
+5,028
+16% +$36.9K ﹤0.01% 3016
2025
Q1 		$239K Sell
30,563
-35,821
-54% -$284K ﹤0.01% 2800
2024
Q4 		$310K Buy
66,384
+54,200
+445% +$283K ﹤0.01% 2722
2024
Q3 		$65.7K Buy
+12,184
New +$86.6K ﹤0.01% 2950

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Investments's INMB Position: Q3 2025 in Review

Two Sigma Investments sold out of INmune Bio (INMB) in Q3 2025, closing a stake of 35,591 shares — an estimated $82.2K sold.

Two Sigma Investments first reported a position in INMB in Q3 2024 and held it in 4 quarters. The position peaked at $310K in Q4 2024. 73 funds tracked by Wall St. Rank hold INMB as of Q3 2025.

  • Two Sigma Investments reported no remaining INmune Bio position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Investments sold 35,591 INmune Bio shares in Q3 2025, an estimated $82.2K.
  • Two Sigma Investments first reported a position in INmune Bio in Q3 2024 and held it in 4 quarters.
  • Two Sigma Investments's INmune Bio position peaked at $310K in Q4 2024.
  • 73 funds tracked by Wall St. Rank held INmune Bio as of Q3 2025.

Based on Two Sigma Investments's 13F filing for Q3 2025, filed 14 Nov 2025.